Literature DB >> 29568870

MicroRNA-599 targets high-mobility group AT-hook 2 to inhibit cell proliferation and invasion in clear cell renal carcinoma.

Hailing Zhao1, Huizhen Zhao1, Xiaolin Xia1, Xiujuan Liu2.   

Abstract

Dysregulation of microRNAs (miRNAs) is associated with the occurrence and development of clear cell renal cell carcinoma (ccRCC) through their participation in a number of critical biological processes. Therefore, an in‑depth investigation into miRNAs and their biological roles within ccRCC may provide useful insights and lead to the identification of novel therapeutic methods for patients with ccRCC. miRNA‑599 (miR‑599) serves critical roles in different types of human cancer. However, the expression pattern, biological function and molecular mechanism of miR‑599 in ccRCC remain unknown. The present study aimed to detect the expression level of miR‑599 in ccRCC, examine its effect on ccRCC progression and further explore the possible underlying mechanisms. It was observed that miR‑599 was significantly underexpressed in ccRCC tissues and cell lines compared with the control. Functional assays revealed that restored expression of miR‑599 restricted the proliferation and invasion of ccRCC cells. Bioinformatics analysis, luciferase reporter assay, reverse transcription‑quantitative polymerase chain reaction and western blot analysis demonstrated that high‑mobility group AT‑hook 2 (HMGA2) was a direct target of miR‑599 in ccRCC. HMGA2 knockdown simulated the suppressive effects caused by miR‑599 overexpression in ccRCC. Recovered HMGA2 expression partially rescued the miR‑599‑mediated inhibition of ccRCC proliferation and invasion. These results suggest that miR‑599 may serve tumour suppressive roles in ccRCC by directly targeting HMGA2, indicating that miR‑599 may have potential as a treatment for patients with ccRCC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29568870     DOI: 10.3892/mmr.2018.8755

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

1.  NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating HMGA2 Transcription through KDM2A-mediated H3K36me2 Demethylation.

Authors:  Jiatian Lin; Xiangling Chen; Hongjian Yu; Shasha Min; Yequn Chen; Zesong Li; Xina Xie
Journal:  Int J Biol Sci       Date:  2022-05-16       Impact factor: 10.750

2.  Effects of BAP1, Ki-67 index, and Id-1 in patients with clear cell renal carcinoma and their correlation with clinical features and prognosis.

Authors:  Jing Yang; Chunyu Gong; Juan Zhao; Lan Chen; Xuefeng Mei; Guangsen Li; Jian Cai
Journal:  Transl Androl Urol       Date:  2020-10

3.  Prognostic Value of HMGA2 in Human Cancers: A Meta-Analysis Based on Literatures and TCGA Datasets.

Authors:  Ben Huang; Jiayi Yang; Qingyuan Cheng; Peipei Xu; June Wang; Zheng Zhang; Wei Fan; Ping Wang; Mingxia Yu
Journal:  Front Physiol       Date:  2018-06-26       Impact factor: 4.566

4.  Long Non-coding RNA LINC01094 Promotes the Development of Clear Cell Renal Cell Carcinoma by Upregulating SLC2A3 via MicroRNA-184.

Authors:  Haifei Xu; Xiaolin Wang; Jiacheng Wu; Hao Ji; Zhigang Chen; Haifeng Guo; Jianquan Hou
Journal:  Front Genet       Date:  2020-09-23       Impact factor: 4.599

5.  Effects of HMGA2 gene silencing on cell cycle and apoptosis in the metastatic renal carcinoma cell line ACHN.

Authors:  Qian Chen; Qizhong Fu; Lin Pu; Xianfeng Liu; Ying Liu
Journal:  J Int Med Res       Date:  2022-02       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.